期刊文献+

Combretastatin A4磷酸酯二钠抑制血管生成作用的研究 被引量:1

Study on antiangiogenesis effect of Combretastatin A4P
原文传递
导出
摘要 目的探讨Combretastatin A4磷酸酯二钠(CA4P)对血管生成的影响。方法建立鸡胚绒毛尿囊膜(CAM)模型及兔角膜新生血管(CNV)模型,评价CA4P对两种模型中血管生成的影响。结果与对照组相比,CA4P高、中剂量具有明显的抑制CAM血管生成的作用(P<0.01或P<0.05);CA4P各剂量对CNV也显示了不同程度的抑制作用(P<0.01或P<0.05)。结论CA4P具有抑制血管生成的作用。 OBJECTIVE To study the antiangiogenesis effect of Combretastatin A4 (CA4P). METHODS CAM and CNV models were established to evaluate the effect of CA4P on the angiogenesis. RESULTS Compared with NS group, the angiogenesis in the CAM which were treated with high dose and middle dose of CA4P had been obviously inhibited(P 〈 0.01 ). The angiogenesis in CNV which were treated with three doses of CA4P had also been inhibited ( P 〈 0.01 ). CONCLUSION CA4P has the antiangiogenesis effect.
出处 《华西药学杂志》 CAS CSCD 北大核心 2009年第5期499-500,共2页 West China Journal of Pharmaceutical Sciences
关键词 COMBRETASTATIN A4磷酸酯二钠 鸡胚绒毛尿囊膜 角膜新生血管 血管生成 Combretastatin A4P CAM CNV Angiogenesis
  • 相关文献

参考文献8

  • 1何应金,张洁,刘静,何雯雯,周莎,田信,徐小平.Combretastatin A4磷酸酯二钠在大鼠体内的药物动力学[J].华西药学杂志,2008,23(6):663-665. 被引量:7
  • 2Lin CM,Singh SB,Chu PS,et al. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin : a structure activity study[ J]. Mol Pharm Acol,1988, 34(2) :200 -208.
  • 3王玮琴,周慧君,陈耀.青蒿琥酯抑制鸡胚尿囊膜血管生成作用的研究[J].中国药学杂志,2006,41(1):22-24. 被引量:10
  • 4刘海俊,向仕平,廖华,张静,谢栋,钟世镇,胡章超.血管抑素抑制兔眼表碱烧伤角膜缘移植术后的角膜血管新生[J].中国临床解剖学杂志,2006,24(5):550-552. 被引量:2
  • 5Elzayat AA, Degen D, Drabek S, et al. In vitro evaluation of the antineop lastic activity of combretastatin A4, a natural p roduct from Corn bretum caffrum ( arid shrub) [J]. Anti Cancer Drugs, 1993, 4(1) :19 -25.
  • 6Vincent L, Kerman IP, YOUNG LM, et al. Combretastatin A4 phosphate induces rap id regression of tumor neovessels and growth through interference with vascular endothelial2cadherin signaling[ J 1. J Clin Invest ,2005,115 ( 11 ) :2992 - 3006.
  • 7任萱 林莉萍 丁健.Combretastatin A4的抗肿瘤作用的研究进展.Chinese J New Drugs,2007,:1336-1406.
  • 8Dark GG, Hill SA, Prise VE,et al. Combretastatin A -4, an agent that displays potent and selective toxicity toward tumor vasculature[ J]. Cancer Res, 1997,57 : 1829 - 1834.

二级参考文献22

  • 1张璇,张健存.抗肿瘤新药——Combretastatin A4磷酸酯[J].中国药房,2007,18(10):779-781. 被引量:5
  • 2CHEN H H,ZHOU H J,WANG W Q,et al.Antimalarial dihydroartemisinin also inhibits angiogenesis [J].Cancer Chemother Pharmacol,2004,53(5) :423-432.
  • 3FUSF.Technology of chick chorioallantoic membrane to test stimulatory factors in angiogenesis[J].军事医学科学院院刊,1993,17(4):294-297.
  • 4SCHLATTER P,KONIG M F,KARLSSON L M,et al.Quantitative study of intussusceptive capillary growth in the chick chorioallantoic membrane(CAM) of the chicken embryo[J].Microvasc Res,1997,54(1):65-73.
  • 5FOLKMAN J.Tumor angiogenesis:therapeutic implications[J].N Engl J Med ,1971,285:1182-1186.
  • 6FOLKMAN J.Clinical applications of research on angiogenesis[J].N Engl J Med,1995,333:1757-1763.
  • 7EFFERTH T,DUNSTAN H,SANERBREYA,etal.The antimalarial aresunate is also active against cancer[J].Int J Oncol,2001,18(4) :767-773.
  • 8SADAVA D,PHILLIPS T,LIN C,et al.Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells [J].Cancer Lett ,2002,179(2):151-156.
  • 9West CML, Price P. Combretastatin A4 phosphate [ J ]. Anti - Cancer Drugs, 2004,15 ( 3 ) : 179 - 187.
  • 10Lippert JW. Vascular disrupting agent [ J ]. Bioorg Med Chem, 2007,15(2) :605 -615.

共引文献16

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部